Dr Reddy's, Alvotech join hands to co-develop, manufacture & commercialise biosimilar of Merck's blockbuster drug Keytruda
HYDERABAD: Dr Reddy's Laboratories has entered into a collaboration and license agreement with Iceland-based biotech player Alvotech for the co-development, manufacturing and commercialiation of a biosimilar of Merck Sharp & Dohme's blockbuster drug Keytruda (pembrolizumab).
Keytruda, which is used for the treatment of various types of cancer, clocked sales of over US$29.5 billion in 2024.
The collaboration will combine Dr Reddy's and Alvotech's capabilities in biosimilars to speed up the development process and extend the global reach of the biosimilar candidate.
As per the agreement, the two companies will share the costs and responsibilities for jointly developing and manufacturing the biosimilar candidate and subject to certain exceptions, each company will have the right to commercialise the product globally, Dr Reddy's said on Thursday.
'The agreement demonstrates Alvotech's ability to leverage its dedicated R&D and manufacturing platform for biosimilars, accelerating the expansion of our pipeline by pursuing growing global markets. It further enables us to increase the availability of cost-effective, critical biologic medications to patients worldwide,' said Róbert Wessman, chairman & CEO, Alvotech.
Dr Reddy's CEO, Erez Israeli, said the pact demonstrates the company's ability to develop and manufacture high-quality and affordable treatment options for patients worldwide.
'Oncology has been a top focus therapy area for us, and this collaboration will further enhance our capabilities in oncology, as pembrolizumab currently represents one of the most critical therapies in immuno-oncology,' Israeli added.
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
34 minutes ago
- Time of India
India to boost rare earth magnet production to counter China's supply curbs: G Kishan Reddy
Union Minister for Coal and Mines G Kishan Reddy on Saturday said that the Central Government has decided to begin the production of rare earth magnets in Hyderabad, as part of its broader push for self-reliance in critical technologies. Speaking to ANI, the minister said, "The Central Government has decided to produce rare earth magnets in Hyderabad. Our Mining Ministry's NFTSM institute is working diligently, along with various industries, to manufacture the necessary machinery." Reddy further added that the government will soon showcase its capabilities in manufacturing permanent magnets. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Brain tumor has left my son feeling miserable; please help! Donate For Health Donate Now Undo "Within the next 3-4 months, they will showcase their efforts in manufacturing permanent magnets. This initiative involves collaboration between the industry, mining, and other ministries, and has been discussed with Prime Minister Narendra Modi. The Central Government is working seriously towards the production of rare earth magnets," he said. Highlighting India's shift in sourcing strategy, the minister noted that India was previously entirely dependent on China for rare-earth permanent magnets. Live Events "We were 100 per cent dependent on China for rare earth permanent magnets, but recently China denied supplying to us," Reddy said. China had announced in April 2024 that it would impose export controls on certain rare earth-related items, triggering a global supply shortage, including in India. In the light of rare earth magnet production, on Friday, Pankaj Mohindroo, Chairman of India Cellular and Electronics Association (ICEA), welcomed the central government initiatives to ramp up rare earth magnet production in India, particularly the incentives the latter is earmarking for. Finance Minister Nirmala Sitharaman announced the setting up of the Critical Mineral Mission in the Union Budget for 2024-25 on July 23, 2024. The Union Cabinet in January 2025 approved the launch of the National Critical Mineral Mission (NCMM) with an expenditure of Rs 16,300 crore and an expected investment of Rs 18,000 crore by Public Sector Undertakings.
&w=3840&q=100)
Business Standard
36 minutes ago
- Business Standard
India first country to launch a traditional knowledge digital library: WHO
In a significant step towards global healthcare innovation, the World Health Organization (WHO) has released a technical brief titled "Mapping the Application of Artificial Intelligence in Traditional Medicine", acknowledging India's pioneering efforts in integrating Artificial Intelligence (AI) with traditional medicine systems, particularly Ayush systems. The WHO release follows India's proposal on the subject, leading to the development of WHO's first-ever roadmap for applying AI in traditional medicine, the Ayush Ministry said in a release. As per the release, India's efforts to harness the potential of Artificial Intelligence (AI) to advance and amplify the strengths of its Ayush systems reflect the broader vision of Prime Minister Narendra Modi, who seeks to position the country as a global leader in digital health innovation and the integration of traditional medicine. Speaking at the inauguration of the Global Partnership on Artificial Intelligence (GPAI) Summit in 2023, Prime Minister Modi said, "We have developed government policies and programmes inspired by the spirit of 'AI for all'. Our endeavour is to take full advantage of the capabilities of AI for social development and inclusive growth." Union Minister of State (Independent Charge) for Ayush and Minister of State for Health & Family Welfare, Prataprao Jadhav, remarked that India's AI-led initiatives, mentioned in WHO's technical brief, reflect the deep commitment of Indian scientists to advancing traditional medicine through cutting-edge technology. The release highlighted that the WHO publication not only validates India's growing influence in the global traditional medicine landscape but also acknowledges several key Indian innovations in the AI and Ayush space. The WHO document showcases a range of AI-driven applications in Ayurveda, Siddha, Unani, Sowa Rigpa, and Homoeopathy, including diagnosis support systems that integrate traditional methods like pulse reading, tongue examination, and Prakriti assessment with machine learning algorithms and deep neural networks. One of the standout features in the WHO brief is the mention of Ayurgenomics, a scientific breakthrough that combines genomics with Ayurvedic principles. This initiative aims to identify predictive disease markers and personalise health recommendations using AI-based analysis of Ayurvedic constitution types. The document also highlights efforts to decode the genomic and molecular basis of herbal formulations for repurposing in modern disease conditions--a major leap in integrating traditional wisdom with contemporary science. India's initiatives to digitise traditional knowledge, such as the Traditional Knowledge Digital Library (TKDL), are praised as global models for the preservation and responsible use of indigenous medical heritage. Furthermore, AI-powered tools are being used for cataloguing and semantic analysis of ancient texts, enabling easier access to time-tested therapeutic knowledge. Another critical aspect recognised by the WHO is the use of AI for identifying drug action pathways, conducting comparative studies across systems such as Ayurveda, TCM, and Unani, and developing artificial chemical sensors to assess traditional parameters like Rasa, Guna, and Virya. These technological interventions are helping to validate and modernise traditional formulations. The document also applauds India's broader efforts in incorporating digital platforms for online consultations, promoting digital literacy among Ayush practitioners, and building interoperable systems to integrate traditional medicine with mainstream healthcare. The Ministry of Ayush has welcomed this recognition as a testament to India's leadership in creating a robust scientific ecosystem for traditional medicine. It also reaffirms the country's commitment to fostering global collaboration and responsible innovation, as envisioned under WHO's broader framework for AI and traditional medicine.
Time of India
41 minutes ago
- Time of India
India first country to launch a Traditional Knowledge Digital Library: WHO
In a significant step towards global healthcare innovation, the World Health Organization (WHO) has released a technical brief titled "Mapping the Application of Artificial Intelligence in Traditional Medicine ", acknowledging India's pioneering efforts in integrating Artificial Intelligence (AI) with traditional medicine systems, particularly Ayush systems . The WHO release follows India's proposal on the subject, leading to the development of WHO's first-ever roadmap for applying AI in traditional medicine, the Ayush Ministry said in a release. As per the release, India's efforts to harness the potential of Artificial Intelligence (AI) to advance and amplify the strengths of its Ayush systems reflect the broader vision of Prime Minister Narendra Modi, who seeks to position the country as a global leader in digital health innovation and the integration of traditional medicine . by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Undo Speaking at the inauguration of the Global Partnership on Artificial Intelligence (GPAI) Summit in 2023, Prime Minister Modi said, "We have developed government policies and programmes inspired by the spirit of 'AI for all'. Our endeavour is to take full advantage of the capabilities of AI for social development and inclusive growth." Union Minister of State (Independent Charge) for Ayush and Minister of State for Health & Family Welfare, Prataprao Jadhav, remarked that India's AI-led initiatives, mentioned in WHO's technical brief, reflect the deep commitment of Indian scientists to advancing traditional medicine through cutting-edge technology. Live Events The release highlighted that the WHO publication not only validates India's growing influence in the global traditional medicine landscape but also acknowledges several key Indian innovations in the AI and Ayush space. The WHO document showcases a range of AI-driven applications in Ayurveda , Siddha, Unani, Sowa Rigpa, and Homoeopathy, including diagnosis support systems that integrate traditional methods like pulse reading, tongue examination, and Prakriti assessment with machine learning algorithms and deep neural networks. One of the standout features in the WHO brief is the mention of Ayurgenomics , a scientific breakthrough that combines genomics with Ayurvedic principles. This initiative aims to identify predictive disease markers and personalise health recommendations using AI-based analysis of Ayurvedic constitution types. The document also highlights efforts to decode the genomic and molecular basis of herbal formulations for repurposing in modern disease conditions--a major leap in integrating traditional wisdom with contemporary science. India's initiatives to digitise traditional knowledge, such as the Traditional Knowledge Digital Library (TKDL), are praised as global models for the preservation and responsible use of indigenous medical heritage. Furthermore, AI-powered tools are being used for cataloguing and semantic analysis of ancient texts, enabling easier access to time-tested therapeutic knowledge. Another critical aspect recognised by the WHO is the use of AI for identifying drug action pathways, conducting comparative studies across systems such as Ayurveda, TCM, and Unani, and developing artificial chemical sensors to assess traditional parameters like Rasa, Guna, and Virya. These technological interventions are helping to validate and modernise traditional formulations. The document also applauds India's broader efforts in incorporating digital platforms for online consultations, promoting digital literacy among Ayush practitioners, and building interoperable systems to integrate traditional medicine with mainstream healthcare. The Ministry of Ayush has welcomed this recognition as a testament to India's leadership in creating a robust scientific ecosystem for traditional medicine. It also reaffirms the country's commitment to fostering global collaboration and responsible innovation, as envisioned under WHO's broader framework for AI and traditional medicine.
